Hypodontia as a risk marker for epithelial ovarian cancer: A case-controlled study

Journal of the American Dental Association

Volumn 139, Issue 2, 2008, Pages 163-169

  Chalothorn, Leigh A ^a,b   Beeman, Cynthia S ^a   Ebersole, Jeffrey L ^a   Kluemper, C Thomas ^a   Hicks, E Preston ^a   Kryscio, Richard J ^c   DeSimone, Christopher P ^a   Modesitt, Susan C ^d  

^a UNIVERSITY OF KENTUCKY   (United States)

^b College of Public Health ^*  (United States)

^c UNIVERSITY OF KENTUCKY COLLEGE OF PUBLIC HEALTH   (United States)

^d UNIVERSITY OF VIRGINIA   (United States)

Author keywords

DNA; Genetics; Hypodontia; Ovarian cancer; Tooth

Indexed keywords

EID: 39749176259     PISSN: 00028177     EISSN: None     Source Type: Journal    
DOI: 10.14219/jada.archive.2008.0132     Document Type: Article

References (37)

1. Thesleff I. The genetic basis of tooth development and dental defects. Am J Med Genet A 2006;140(23):2530-5.
2. Tooth and Craniofacial Development Group of the Developmental Biology Programme, Institute of Biotechnology, University of Helsinki. Gene expression in tooth development. Available at: "http://bite-it. helsinki.fi". Accessed Jan. 5, 2007.
3. Lammi L, Arte S, Somer M, et al. Mutations in AXIN2 cause familial tooth agenesis and predispose to colorectal cancer. Am J Hum Genet 2004;74(5):1043-50.
4. Liu W, Dong X, Mai M, et al. Mutations in AXIN2 cause colorectal cancer with defective mismatch repair by activating beta-catenin/TCF signalling. Nat Genet 2000;26(2):146-7.
5. Mostowska A, Biedziak B, Jagodzinski PP. Axis inhibition protein 2 (AXIN2) polymorphisms may be a risk factor for selective tooth agenesis. J Hum Genet 2006;51(3):262-6.
6. Gerber JK, Richter T, Kremmer E, et al. Progressive loss of PAX9 expression correlates with increasing malignancy of dysplastic and cancerous epithelium of the human oesophagus. J Pathol 2002;197(3): 293-7.
7. Thesleff I. Homeobox genes and growth factors in regulation of craniofacial and tooth morphogenesis. Acta Odontol Scand 1995;53(3): 129-34.
8. Thesleff I. The genetic basis of normal and abnormal craniofacial development. Acta Odontol Scand 1998;56(6):321-5.
9. Larmour CJ, Mossey PA, Thind BS, Forgie AH, Stirrups DR. Hypodontia: a retrospective review of prevalence and etiology, part I. Quintessence Int 2005;36(4):263-70.
10. Peck S, Peck L, Kataja M. Concomitant occurrence of canine malposition and tooth agenesis: evidence of orofacial genetic fields. Am J Orthod Dentofacial Orthop 2002;122(6):657-60.
11. Vastardis H. The genetics of human tooth agenesis: new discoveries for understanding dental anomalies. Am J Orthod Dentofacial Orthop 2000;117(6):650-6.
12. Brook AH. A unifying aetiological explanation for anomalies of human tooth number and size. Arch Oral Biol 1984;29(5):373-8.
13. Mattheeuws N, Dermaut L, Martens G. Has hypodontia increased in Caucasians during the 20th century? A meta-analysis. Eur J Orthod 2004;26(1);99-103.
14. Stockton DW, Das P, Goldenberg M, D'Souza RN, Patel PI. Mutation of PAX9 is associated with oligodontia. Nat Genet 2000;24(1):18-9.
15. Vastardis H, Karimbux N, Guthua SW, Seidman JG, Seidman CE. A human MSXl homeodomain missense mutation causes selective tooth agenesis. Nat Genet 1996;13(4):417-21.
16. Frazier-Bowers SA, Guo DC, Cavender A, et al. A novel mutation in human PAX9 causes molar oligodontia. J Dent Res 2002;81(2): 129-33.
17. van den Boogaard MJ, Dorland M, Beemer FA, van Amstel HK. MSX1 mutation is associated with orofacial clefting and tooth agenesis in humans. Nat Genet 2000;24(4):342-3.
18. Lidral AC, Reising BC. The role of MSX1 in human tooth agenesis. J Dent Res 2002;81(4):274-8.
19. Jumlongras D, Lin JY, Chapra A, et al. A novel missense mutation in the paired domain of PAX9 causes non-syndromic oligodontia. Hum Genet 2004;114(3):242-9.
20. Klein ML, Nieminen P, Lammi L, Niebuhr E, Kreiborg S. Novel mutation of the initiation codon of PAX9 causes oligodontia. J Dent Res 2005;84(1):43-7.
21. Mostowska A, Kobielak A, Trzeciak WH. Molecular basis of nonsyndromic tooth agenesis: mutations of MSX1 and PAX9 reflect their role in patterning human dentition. Eur J Oral Sci 2003;111(5):365-70.
22. Kolenc-Fusé FJ. Tooth agenesis: in search of mutations behind failed dental development. Med Oral Patol Oral Cir Bucal 2004;9(5):385-95.
23. Chen Y, Bei M, Woo I, Satokata I, Maas R. Msx1 controls inductive signaling in mammalian tooth morphogenesis. Development 1996; 122(10):3035-44.
24. Peters H, Balling R. Teeth. Where and how to make them. Trends Genet 1999;15(2);59-65.
25. Alappat S, Zhang ZY, Chen YP. Msx homeobox gene family and craniofacial development. Cell Res 2003;13(6):429-42.
26. Leung JY, Kolligs FT, Wu R, et al. Activation of AXIN2 expression by beta-catenin-T cell factor. A feedback repressor pathway regulating Wnt signaling. J Biol Chem 2002;277(24):21657-65.
27. Salahshor S, Woodgett JR. The links between axin and carcinogenesis. J Clin Pathol 2005;58(3):225-36.
28. Nunes FD, de Almeida FC, Tucci R, de Sousa SC. Homeobox genes: a molecular link between development and cancer. Pesqui Odontol Bras 2003;17(1):94-8.
29. Samuel S, Naora H. Homeobox gene expression in cancer: insights from developmental regulation and deregulation. Eur J Cancer 2005;41(16):2428-37.
30. Park K, Kim K, Rho SB, et al. Homeobox Msx1 interacts with p53 tumor suppressor and inhibits tumor growth by inducing apoptosis. Cancer Res 2005;65(3):749-57.
31. Park J, Park K, Kim S, Lee JH. Msx1 gene overexpression induces G1 phase cell arrest in human ovarian cancer cell line OVCAR3. Biochem Biophys Res Commun 2001;281(5):1234-40.
32. American Cancer Society. Available at: "www.cancer.org". Accessed April 4, 2007.
33. Bast RC Jr, Brewer M, Zou C., et al. Prevention and early detection of ovarian cancer: mission impossible? Recent Results Cancer Res 2007;174:91-100.
34. Wu R, Zhai Y, Fearon ER, Cho KR. Diverse mechanisms of betacatenin deregulation in ovarian endometrioid adenocarcinomas. Cancer Res 2001;61(22):8247-55.
35. Schwartz DR, Wu R, Kardia SL, et al. Novel candidate targets of beta-catenin/T-cell factor in signaling identified by gene expression profiling of ovarian endometrioid adenocarcinomas. Cancer Res 2003;63(11):2913-22.
36. Jones F, Kioussi C, Copertino D, Kallunki P, Hoist B, Edelman G. Barx2, a new homeobox gene of the Bar class, is expressed in neural and craniofacial structures during development. Proc Natl Acad Sci U S A 1997;94(6):2632-7.
37. Sellar GC, Li L, Watt KP, et al. BARX2 induces Cadherin 6 expression and is a functional suppressor of ovarian cancer progression. Cancer Res 2001;61(19):6977-81.